IFIT1 and breast cancer: In early-stage breast cancer patients treated with breast-conserving surgery and radiation therapy with or without chemotherapy and/or adjuvant hormone therapy, IFIT1 protein has been shown to act as a favorable prognostic marker for local control [31].